T1	p 205 245	patients with atrial fibrillation ( AF )
T2	p 715 781	patients with nonvalvular AF and at least 1 risk factor for stroke
T3	p 822 837	18,113 patients
T4	p 840 920	Patients who were VKA-naive and experienced are included in balanced proportions
T5	i 97 105	warfarin
T6	i 122 132	dabigatran
T7	i 273 293	Dabigatran etexilate
T8	i 373 383	dabigatran
T9	i 478 486	warfarin
T10	i 560 570	dabigatran
T11	i 1430 1440	dabigatran
T12	o 946 978	stroke ( including hemorrhagic )
T13	o 982 999	systemic embolism
T14	o 1022 1088	bleeding , liver function abnormalities , and other adverse events